Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.

Sandborn WJ, Feagan BG, Marano C, Zhang H, Strauss R, Johanns J, Adedokun OJ, Guzzo C, Colombel JF, Reinisch W, Gibson PR, Collins J, Järnerot G, Rutgeerts P; PURSUIT-Maintenance Study Group.

Gastroenterology. 2014 Jan;146(1):96-109.e1. doi: 10.1053/j.gastro.2013.06.010. Epub 2013 Jun 14.

PMID:
23770005
2.

Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.

Sandborn WJ, Feagan BG, Marano C, Zhang H, Strauss R, Johanns J, Adedokun OJ, Guzzo C, Colombel JF, Reinisch W, Gibson PR, Collins J, Järnerot G, Hibi T, Rutgeerts P; PURSUIT-SC Study Group.

Gastroenterology. 2014 Jan;146(1):85-95; quiz e14-5. doi: 10.1053/j.gastro.2013.05.048. Epub 2013 Jun 2.

PMID:
23735746
3.

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.

Sjöberg M, Walch A, Meshkat M, Gustavsson A, Järnerot G, Vogelsang H, Hertervig E, Novacek G, Friis-Liby I, Blomquist L, Angelberger S, Karlen P, Grännö C, Vilien M, Ström M, Verbaan H, Hellström PM, Dejaco C, Magnuson A, Halfvarson J, Reinisch W, Tysk C.

Inflamm Bowel Dis. 2012 Feb;18(2):212-8. doi: 10.1002/ibd.21680. Epub 2011 Mar 15.

PMID:
21438096
4.

Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.

Gustavsson A, Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Verbaan H, Hellström PM, Magnuson A, Halfvarson J, Tysk C.

Aliment Pharmacol Ther. 2010 Oct;32(8):984-9. doi: 10.1111/j.1365-2036.2010.04435.x. Epub 2010 Aug 18.

5.

A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.

Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, Järnerot G, Tysk C, Jansson JK, Engstrand L.

Gastroenterology. 2010 Dec;139(6):1844-1854.e1. doi: 10.1053/j.gastro.2010.08.049. Epub 2010 Oct 8.

PMID:
20816835
6.

Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease.

Willing B, Halfvarson J, Dicksved J, Rosenquist M, Järnerot G, Engstrand L, Tysk C, Jansson JK.

Inflamm Bowel Dis. 2009 May;15(5):653-60. doi: 10.1002/ibd.20783.

PMID:
19023901
7.

Treatment of choice for acute severe steroid-refractory ulcerative colitis is remicade.

Halfvarson J, Järnerot G.

Inflamm Bowel Dis. 2009 Jan;15(1):143-5. doi: 10.1002/ibd.20782. Review. No abstract available.

PMID:
18942766
8.

How to judge the response to treatment in ulcerative colitis?

Järnerot G.

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S222-3. doi: 10.1002/ibd.20546. No abstract available. Erratum in: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47.

PMID:
18816742
9.

Molecular analysis of the gut microbiota of identical twins with Crohn's disease.

Dicksved J, Halfvarson J, Rosenquist M, Järnerot G, Tysk C, Apajalahti J, Engstrand L, Jansson JK.

ISME J. 2008 Jul;2(7):716-27. doi: 10.1038/ismej.2008.37. Epub 2008 Apr 10.

PMID:
18401439
10.

Short health scale: a valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease.

Stjernman H, Grännö C, Järnerot G, Ockander L, Tysk C, Blomberg B, Ström M, Hjortswang H.

Inflamm Bowel Dis. 2008 Jan;14(1):47-52.

PMID:
17828783
11.

Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease.

Halfvarson J, Jess T, Bodin L, Järnerot G, Munkholm P, Binder V, Tysk C.

Inflamm Bowel Dis. 2007 Dec;13(12):1536-44.

PMID:
17828780
12.

Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era.

Gustavsson A, Halfvarson J, Magnuson A, Sandberg-Gertzén H, Tysk C, Järnerot G.

Am J Gastroenterol. 2007 Nov;102(11):2513-9. Epub 2006 Aug 4.

PMID:
17680849
13.

Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population.

Halfvarson J, Jess T, Magnuson A, Montgomery SM, Orholm M, Tysk C, Binder V, Järnerot G.

Inflamm Bowel Dis. 2006 Oct;12(10):925-33.

PMID:
17012962
14.

The Short Health Scale: a valid measure of subjective health in ulcerative colitis.

Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, Almer S, Ström M.

Scand J Gastroenterol. 2006 Oct;41(10):1196-203.

PMID:
16990205
15.

Evaluation of the Inflammatory Bowel Disease Questionnaire in Swedish patients with Crohn's disease.

Stjernman H, Grännö C, Bodemar G, Järnerot G, Ockander L, Tysk C, Blomberg B, Almer S, Ström M, Hjortswang H.

Scand J Gastroenterol. 2006 Aug;41(8):934-43.

PMID:
16803692
16.

Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients.

Bodger K, Halfvarson J, Dodson AR, Campbell F, Wilson S, Lee R, Lindberg E, Järnerot G, Tysk C, Rhodes JM.

Gut. 2006 Jul;55(7):973-7. Epub 2006 Feb 4.

17.

Infliximab or cyclosporine for severe ulcerative colitis.

Järnerot G.

Gastroenterology. 2006 Jan;130(1):286; author reply 287. No abstract available.

PMID:
16401502
18.

[Microscopic colitis--more common cause of diarrhea than believed. Biopsies are the only way to diagnosis, drug treatment is effective].

Tysk C, Bohr J, Olesen M, Eriksson S, Järnerot G.

Lakartidningen. 2005 Aug 8-21;102(32-33):2210-4. Review. Swedish.

PMID:
16145878
19.

CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.

Halfvarson J, Bresso F, D'Amato M, Järnerot G, Pettersson S, Tysk C.

Dig Liver Dis. 2005 Oct;37(10):768-72.

PMID:
16002353
20.

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Danielsson A, Verbaan H, Hellström PM, Magnuson A, Curman B.

Gastroenterology. 2005 Jun;128(7):1805-11.

PMID:
15940615
21.

Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease.

Halfvarson J, Standaert-Vitse A, Järnerot G, Sendid B, Jouault T, Bodin L, Duhamel A, Colombel JF, Tysk C, Poulain D.

Gut. 2005 Sep;54(9):1237-43. Epub 2005 Apr 29.

22.

Colonic perforation in collagenous colitis: an unusual complication.

Bohr J, Larsson LG, Eriksson S, Järnerot G, Tysk C.

Eur J Gastroenterol Hepatol. 2005 Jan;17(1):121-4. Review.

PMID:
15647652
23.

Antibody levels in adult patients with coeliac disease during gluten-free diet: a rapid initial decrease of clinical importance.

Midhagen G, Aberg AK, Olcén P, Järnerot G, Valdimarsson T, Dahlbom I, Hansson T, Ström M.

J Intern Med. 2004 Dec;256(6):519-24.

24.

Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients.

Olesen M, Eriksson S, Bohr J, Järnerot G, Tysk C.

Gut. 2004 Apr;53(4):536-41.

25.

Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998.

Olesen M, Eriksson S, Bohr J, Järnerot G, Tysk C.

Gut. 2004 Mar;53(3):346-50.

26.

The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis.

Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, Almer S, Ström M.

Eur J Gastroenterol Hepatol. 2003 Sep;15(9):1011-20.

PMID:
12923375
27.

Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics.

Halfvarson J, Bodin L, Tysk C, Lindberg E, Järnerot G.

Gastroenterology. 2003 Jun;124(7):1767-73.

PMID:
12806610
28.

Luminal nitric oxide and epithelial expression of inducible and endothelial nitric oxide synthase in collagenous and lymphocytic colitis.

Olesen M, Middelveld R, Bohr J, Tysk C, Lundberg JO, Eriksson S, Alving K, Järnerot G.

Scand J Gastroenterol. 2003 Jan;38(1):66-72.

PMID:
12608467
29.

Yersinia species in collagenous colitis: a serologic study.

Bohr J, Nordfelth R, Järnerot G, Tysk C.

Scand J Gastroenterol. 2002 Jun;37(6):711-4.

PMID:
12126251
30.

Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC).

Broomé U, Glaumann H, Lindstöm E, Lööf L, Almer S, Prytz H, Sandberg-Gertzén H, Lindgren S, Fork FT, Järnerot G, Olsson R.

J Hepatol. 2002 May;36(5):586-9.

PMID:
11983440
31.

Effect of fasting on diarrhoea in collagenous colitis.

Bohr J, Järnerot G, Tysk C, Jones I, Eriksson S.

Digestion. 2002;65(1):30-4.

PMID:
11961340
32.

Familial occurrence of microscopic colitis: a report on five families.

Järnerot G, Hertervig E, Grännö C, Thorhallsson E, Eriksson S, Tysk C, Hansson I, Björknäs H, Bohr J, Olesen M, Willén R, Kagevi I, Danielsson A.

Scand J Gastroenterol. 2001 Sep;36(9):959-62.

PMID:
11521987
33.

Laparoscopic appendectomy in patients with refractory ulcerative colitis.

Järnerot G, Andersson M, Franzén L.

Gastroenterology. 2001 May;120(6):1562-3. No abstract available.

PMID:
11339237
34.

Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis.

Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, Almer S, Ström M.

Scand J Gastroenterol. 2001 Jan;36(1):77-85.

PMID:
11218243
35.

Collagenous and lymphocytic colitis: a clinical and histopathological review.

Bohr J, Olesen M, Tysk C, Järnerot G.

Can J Gastroenterol. 2000 Dec;14(11):943-7. Review.

PMID:
11125185
36.

Allopurinol in addition to 5-aminosalicylic acid based drugs for the maintenance treatment of ulcerative colitis.

Järnerot G, Ström M, Danielsson A, Kilander A, Lööf L, Hultcrantz R, Löfberg R, Florén C, Nilsson A, Broström O.

Aliment Pharmacol Ther. 2000 Sep;14(9):1159-62.

37.

Clinical evaluation and management of acute severe colitis.

Blomberg B, Järnerot G.

Inflamm Bowel Dis. 2000 Aug;6(3):214-27. Review.

PMID:
10961594
38.

Hermansky-Pudlak syndrome with colitis and pulmonary fibrosis.

Sandberg-Gertzén H, Eid R, Järnerot G.

Scand J Gastroenterol. 1999 Oct;34(10):1055-6.

PMID:
10563678
39.

Low circulating insulin-like growth factor I in coeliac disease and its relation to bone mineral density.

Valdimarsson T, Arnqvist HJ, Toss G, Järnerot G, Nyström F, Ström M.

Scand J Gastroenterol. 1999 Sep;34(9):904-8.

PMID:
10522610
40.

Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological features.

Olsson R, Broomé U, Danielsson A, Hägerstrand I, Järnerot G, Lööf L, Prytz H, Rydén BO.

Hepatogastroenterology. 1999 Jan-Feb;46(25):136-41.

PMID:
10228778
41.

A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.

Hultcrantz R, Olsson R, Danielsson A, Järnerot G, Lööf L, Ryden BO, Wahren B, Broomé U.

J Hepatol. 1999 Apr;30(4):669-73.

PMID:
10207809
42.

Crohn's disease.

Sjödahl R, Järnerot G.

Eur J Surg. 1998 Dec;164(12):883-6. No abstract available.

PMID:
10029381
43.

Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence?

Söderholm JD, Olaison G, Lindberg E, Hannestad U, Vindels A, Tysk C, Järnerot G, Sjödahl R.

Gut. 1999 Jan;44(1):96-100.

44.

Medical therapy of active Crohn's disease.

Järnerot G, Sandberg-Gertzén H, Tysk C.

Baillieres Clin Gastroenterol. 1998 Mar;12(1):73-92. Review.

PMID:
9704156
45.
46.

Increased nitric oxide production in collagenous and lymphocytic colitis.

Lundberg JO, Herulf M, Olesen M, Bohr J, Tysk C, Wiklund NP, Morcos E, Hellström PM, Weitzberg E, Järnerot G.

Eur J Clin Invest. 1997 Oct;27(10):869-71.

PMID:
9373768
47.

Cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis.

Rautelin H, Blomberg B, Fredlund H, Järnerot G, Danielsson D.

Gut. 1997 Mar;40(3):431. No abstract available.

48.

Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients.

Bohr J, Tysk C, Eriksson S, Abrahamsson H, Järnerot G.

Gut. 1996 Dec;39(6):846-51.

49.
50.

Autoantibodies and immunoglobulins in collagenous colitis.

Bohr J, Tysk C, Yang P, Danielsson D, Järnerot G.

Gut. 1996 Jul;39(1):73-6.

Supplemental Content

Loading ...
Support Center